Discovery of Small Molecules Targeting Norovirus 3CL Protease by Multi-Stage Virtual Screening
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125625 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zhongling Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical S…. Hauptthemen laut MEDLINE: Norovirus, Antiviral Agents, Small Molecule Libraries, Viral Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Shandong Laboratory Program, the Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Human noroviruses (HuNoVs) are the primary cause of acute viral gastroenteritis. There are no antivirals or vaccines available to treat and/or prevent HuNoV. Norovirus 3C-like protease (3CLpro) is essential for viral replication; consequently, the inhibition of this enzyme is a fruitful avenue for antinorovirus therapeutics. To discover novel 3CLpro inhibitors with diverse scaffolds, a multi-stage virtual screening approach was performed by docking >10 million compounds into the 3CLpro catalytic site. An initial subset of 18 compounds was selected, and compounds YY-1029 and YY-4204 were identified as the best two molecules. Molecular dynamics (MD) simulations and binding free energy calculations (MM/GBSA) of YY-1029 and YY-4204 were performed to elucidate the binding mechanisms. The ADMET properties were also estimated to predict the potential druggability of representative molecules. All 18 compounds were evaluated for their antinorovirus activity and cytotoxicity in a cell-based replicon system. This work could provide information for the development of 3CL pro inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Cul…
- Molecular, Structural and Translational Virology Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
- Antiviral Drug & Vaccine Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
ORCID-Profile: Dongwei Kang, Steven De Jonghe, Johan Neyts, Xinyong Liu
Förderung
- the National Natural Science Foundation of China
- the Shandong Laboratory Program
- the Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Shandong Laboratory Program
- Natural Science Foundation of Shandong Province
Zitieren
APA
Shi, Z., Liu, N., Zhao, F., Kang, D., De Jonghe, S., Neyts, J., Gao, N., & Liu, X. (2025). Discovery of Small Molecules Targeting Norovirus 3CL Protease by Multi-Stage Virtual Screening. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125625
Vancouver
Shi Z, Liu N, Zhao F, Kang D, De Jonghe S, Neyts J, et al. Discovery of Small Molecules Targeting Norovirus 3CL Protease by Multi-Stage Virtual Screening. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125625
BibTeX
@article{Shi2025,
author = {Shi, Zhongling and Liu, Na and Zhao, Fabao and Kang, Dongwei and De Jonghe, Steven and Neyts, Johan and Gao, Ni and Liu, Xinyong},
title = {Discovery of Small Molecules Targeting Norovirus 3CL Protease by Multi-Stage Virtual Screening},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125625}
}
EUVIMED